[
  {
    "ts": null,
    "headline": "Should You Buy Shares of CRISPR Therapeutics in February?",
    "summary": "The company could finally be ready to deliver on years of promise.",
    "url": "https://finnhub.io/api/news?id=89d64b3d63caaf65bcec99717efc3d6f0d446178b409f63f9162ee4ccc8c6545",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771427580,
      "headline": "Should You Buy Shares of CRISPR Therapeutics in February?",
      "id": 139136706,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The company could finally be ready to deliver on years of promise.",
      "url": "https://finnhub.io/api/news?id=89d64b3d63caaf65bcec99717efc3d6f0d446178b409f63f9162ee4ccc8c6545"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
    "summary": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
    "url": "https://finnhub.io/api/news?id=ed19358bc61bc5411b8ccd08d458eb0523fcbeeed031db84d14f0700816c4ad8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771422295,
      "headline": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
      "id": 139138311,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ed19358bc61bc5411b8ccd08d458eb0523fcbeeed031db84d14f0700816c4ad8"
    }
  },
  {
    "ts": null,
    "headline": "Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash",
    "summary": "Vertex has the revenue power to excel during any market environment.",
    "url": "https://finnhub.io/api/news?id=e4257b3265ac32b69e9cd7381d40a575721266ee2cc895de8855dfa03ebaf66f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771407300,
      "headline": "Vertex: The Quiet Biotech Compounder I'd Happily Hold Through Any Market Crash",
      "id": 139131575,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex has the revenue power to excel during any market environment.",
      "url": "https://finnhub.io/api/news?id=e4257b3265ac32b69e9cd7381d40a575721266ee2cc895de8855dfa03ebaf66f"
    }
  }
]